Antileishmanial 2-substituted quinolines: In vitro behaviour towards biological components

Biomedicine and Pharmacotherapy

Volumn 61, Issue 7, 2007, Pages 441-450

  Desrivot, Julie ^a   Herrenknecht, Christine ^a   Ponchel, Gilles ^b   Garbi, Najla ^b   Prina, Eric ^c   Fournet, Alain ^d   Bories, Christian ^a   Figadère, Bruno ^a   Hocquemiller, Reynald ^a   Loiseau, Philippe M ^a  

^a UNIVERSITÉ PARIS SUD   (France)

^b UNIV PARIS SUD   (France)

^c INSTITUT PASTEUR   (France)

^d Centre Pharmaceutique   (France)

Author keywords

2 Substituted quinolines; In vitro interaction

Indexed keywords

QUINOLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BLOOD COMPONENT; CONTROLLED STUDY; DRUG ACTIVITY; ERYTHROCYTE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARASITE; PRIORITY JOURNAL; RAT; TEMPERATURE;

ANIMALS; ANTIPROTOZOAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; INHIBITORY CONCENTRATION 50; LEISHMANIA DONOVANI; LEISHMANIA MEXICANA; MALE; MICE; PARASITIC SENSITIVITY TESTS; QUINOLINES; RATS; RATS, WISTAR; SOLID PHASE EXTRACTION; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE;

EID: 34547737348     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.03.004     Document Type: Article

References (31)

1. WHO. Progress Report 2002. Global defense against the infectious disease threat (2002). http://www.who.int/infectious-disease-news/cds2002/chapter5.pdf
2. Murray H.W., Berman J.D., Davies C.R., and Saravia N.C. Advances in leishmaniasis. Lancet 366 (2005) 1561
3. Seifert K., Matu S., Pérez-Victoria F.J., Castanys S., Gamarro F., and Croft S.L. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int J Antimicrob Aging 22 (2003) 380
4. Fournet A., Barrios A.A., Munoz V., Hocquemiller R., Cavé A., and Bruneton D. 2-substituted quinoline alkaloids as potential antileishmanial drugs. Antimicrob Agents Chemother 37 (1993) 859
5. Fournet A., Gantier J.C., Gautheret A., Leysalles L., Munos M.H., Mayrargue J., et al. The activity of 2-substituted quinoline alkaloids in BALB/c mice infected with Leishmania donovani. J Antimicrob Chemother 33 (1994) 537
6. Nakayama H., Loiseau P.M., Bories C., Torres De Ortoz S., Shinini A., Serna E., et al. Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniasis. Antimicrob Agents Chemother 49 (2005) 4950
7. Nakayama H, Desrivot J, Bories C, Franck X, Figadère B, Hocquemiller R, et al. In vitro and in vivo antileishmanial efficacy of nitrilquinoline against Leishmania donovani. Biomed Pharmacother 2007; [epub ahead of print].
8. Fakhfakh M.A., Fournet A., Prina E., Mouscadet J.F., Franck X., Hocquemiller R., et al. Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections. Bioorg Med Chem 11 (2003) 5013
9. Desrivot J, Moussa F, Champy P, Fournet A, Figadère B, Herrenknecht C. Development of a SPE/HPLC/DAD method for the determination of antileishmanial 2-substituted quinolines and metabolites in rat plasma. In press.
10. Martínez-Grueiro M., Giménez-Pardo C., Gómez-Barrio A., Franck X., Fournet A., Hocquemiller R., et al. Nematocidal and trichomonacidal activities of 2-substituted quinolines. Il Farmaco 60 (2005) 219
11. Hui X., Desrivot J., Bories C., Loiseau P.M., Franck X., Hocquemiller R., et al. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxaline. Bioorg Med Chem Lett 16 (2006) 815
12. Feder R., Nehushtai R., and Mor A. Affinity driven molecular transfer from erythrocyte membrane to target cells. Peptides 22 (2001) 1683
13. Antoine J.C., Jouanne C., and Ryter A. Megasomes as the targets of leucine methyl ester in Leishmania amazonensis amastigotes. Parasitology 99 Pt 1 (1989) 1-9
14. Castillo M., Lam Y.W.F., Dooley M.A., Stahl E., and Smith P.C. Disposition and covalent binding of ibuprofen and its acyl glucuronide in the elderly. Clin Pharmacol Ther 57 (1995) 636
15. Carfi M, Gennari A, Malerba I, Corsini E, Pallardy M, Pieters R, et al. In vitro tests to evaluate immunotoxicity: A preliminary study. Toxicology 207; 229: 11.
16. Hinderling P.H. Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics. Pharmacol Rev 49 (1997) 279
17. Beaumont C., and Canonne-Hergaux F. Erythrophagocytosis and recycling of heme iron in normal and pathological conditions; regulation by hepcidin. Transfus Clin Biol 12 (2005) 123
18. DeLoach J.R., Andrews K., and Naqi A. Targeting of mycotoxins to reticuloendothelial system of mice with carrier erythrocytes. Biotechnol Appl Biochem 10 (1988) 154
19. Jordán J.A., Murciano J.C., Lotero A., Herráez A., and Díez J.C. In vitro properties and organ uptake of rat band 3 cross-linked erythrocytes. Biochimie 79 (1997) 53
20. Jordán J.A., Alvarez F.J., Lotero L.A., Olmos G., Calleja P., Tejedor M.C., et al. Differential induction of macrophage recognition of carrier erythrocytes by treatment with band 3 cross-linkers. Biotechnol Appl Biochem 27 (1998) 133
21. Jordán J.A., Alvarez F.J., Tejedor M.C., and Díez J.C. B and 3 crosslinking-induced targeting of mouse carrier erythrocyte. Biotechnol Appl Biochem 29 (1999) 59
22. Krantz A. Red cell-mediated therapy: Opportunities and challenges. Blood Cells Mol Dis 23 (1997) 58
23. Aminoff D. The role of sialoglycoconjugates in the aging and sequestration of red cells from circulation. Blood Cells 14 (1988) 229
24. Ries C.A., Rosembaum T.J., Garraty G., Petz L.D., and Fudenberg H.H. Penicillin-induced immune haemolytic anemia. Occurrence of massive intravascular haemolysis. JAMA 233 (1975) 432
25. Denz H., Spath P., and Huber H.P. Penicillin-induced immune haemolytic anemia. In vitro studies using separated monocytes. Blut 35 (1977) 171
26. Zhou S. Separation and detection methods for covalent drug-protein adducts. J Chromatogr B 797 (2003) 63
27. Iglarz M., Baune B., Gantier J.C., Hocquemiller R., and Farinotti R. Determination of 2-n-propylquinoline in mouse plasma and liver by high-performance liquid chromatography. J Chromatogr B 714 (1998) 335
28. Millán C.G., Marinero M.L.S., Castañeda A.Z., and Lanao J.M. Drug, enzyme and peptide delivery using erythrocytes as carrier. J Controlled Release 95 (2004) 27
29. Ariyanayagam M.R., and Fairlamb A.H. Ovothiol and trypanothione as antioxidants in trypanosomatids. Mol Biochem Parasitol 115 (2001) 189
30. Turrens J.F. Oxidative stress and antioxidant defenses: a target for the treatment of diseases caused by parasitic protozoa. Mol Aspects Med 25 (2004) 211
31. Ouellette M., Drummelsmith J., and Papadopoulou B. Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist Update 7 (2004) 257